Skip to main content

Revvity Reconciliati on of financial organic revenue growth from continuing operations (change on a year)

  • RVTY · NYSE
  • Instruments
  • Health Care Equipment
  • S&P 500
$154.39−1.67%Close 13 Nov 2026 · Market value $16.71B

Reconciliati on of financial organic revenue growth from continuing operations (change on a year) at Revvity came to 3% for the quarter to 5 Apr 2026, down 1.0 points from a year earlier.

As Revvity reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 5 May 2026.

By quarter

−3%Mar 2024−1%Jun 20242%Sep 20246%Dec 20244%Mar 20253%Jun 20251%Sep 20254%Dec 20253%Apr 2026
Revvity Reconciliati on of financial organic revenue growth from continuing operations (change on a year), every reported period
Period endingReconciliati on of financial organic revenue growth from continuing operations (change on a year)Change on a yearFiled
5 Apr 20263%down 1.0 points5 May 2026
28 Dec 20254%down 2.0 points13 Jan 2026
28 Sep 20251%down 1.0 points27 Oct 2025
29 Jun 20253%up 4.0 points28 Jul 2025
30 Mar 20254%up 7.0 points28 Apr 2025
29 Dec 20246%—13 Jan 2025
29 Sep 20242%—4 Nov 2024
30 Jun 2024−1%—29 Jul 2024
31 Mar 2024−3%—29 Apr 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Shown as the change on the same period a year earlier, as the company prints it. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Revvity: Product revenue · Service revenue · Life Sciences revenue · Diagnostics revenue · United States revenue · China revenue · Americas revenue · Europe revenue · Germany revenue · Asia revenue · United Kingdom revenue · financial statements

Every KPI and segment of RVTY, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.